Suggestive of greater resistance to M-CSF effects, levels of CD33C2 in the M-CSF treated SLE cells did not reach the baseline levels observed in healthy monocytes, although they were higher than the GM-CSF + IL-4 treated SLE cells. Here, IL4 is linked to systemic lupus erythematosus.